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Introduction  
Toxoplasmosis is relatively prevalent 
parasitic disease which is common between 
humans and warm-blooded animals. This 
disease has a wide distribution globally and 
also its prevalence in Iran varies in different 
locations (1). In a study on congenital 
toxoplasmosis    which   was  performed  in                                          
Amol City, the results indicated that 75.7% 
of mothers and 47.7% of infants had specific 
IgG antibody and 0.2% were mothers with 
IgM antibody, but none of the babies were 
positive in terms of IgM antibody (2).The 
prevalence of toxoplasmosis is diverse in 
pregnant women from different parts of the 
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world. The results of an investigation (1995) 
showed that in 53.9% pregnant women IgG 
antibodies are positive (3). In another 
research conducted on pregnant women, it 
has been reported the percents of women 
with positive antibodies were 83% in Paris, 
31.7% in the United States, 49% in Algeria, 
12% in Norway and 22% in London (4-5).  
Diagnosis: If there is possibility of 
development of toxoplasmosis in the fetus 
due to the recent development of this disease 
in the mother or the ultrasonography 
findings associated with the fetus, 
supplementary tests will be needed (6).   
When some disorders (such as placenta 
hyperdensity, numerous intracranial lesions, 
ventricular dilatation, liver lesions, 
hepatosplenomegaly, plural effusion, 
pericardial effusion, and ascites) are 
observed in the fetus through 
ultrasonography, there is a possibility for 
presence of toxoplasmosis. However, 
decisive diagnosis of this disease in fetus 
requires observation of the parasite in blood 
or the amniotic liquid. It is also possible to 
examine the fetal blood for presence of IgM 
or IgA antibodies. Today, with the 
accessibility of polymerase chain reaction 
(PCR) tests, this method is preferred to other 
methods (7). If the PCR examination of the 
amniotic liquid is positive and the results of 
fetal ultrasonography is normal, the PCR 
test needs to be repeated in another 
laboratory first of all. The reason is that 
diagnosis of this by this method requires 
highly precise laboratory procedures (8-9). 
There is disagreement on the screening of all 
pregnant women based on presence of 
toxoplasmosis. However, this is done in 
some parts of the world (10).  
Treatment: In non-pregnant women with a 
healthy immune system, there is often no 
need for treatment. However, if a pregnant 
woman develops the acute form of 
toxoplasmosis, she shall be treated 
immediately. There are different medicines 
for the treatment of this disease which 
include Spiramycin, Pyrimethamine, 
Sulfadiazine, and Azithromycin (11-14). 
Spiramycin scatters in the placenta and 
prevents transmission of the infection from 
the mother to the fetus. However, there is 
controversy over this function (11, 15). 
Since little concentrations of this drug reach 
the fetus, it cannot treat the disease in the 
fetus if the parasite is already in the fetus. 
Hence, four weeks after the onset of acute 
infection in pregnant mothers in their second 
trimester the amniotic liquid needs to be 
examined through PCR. Then if there is a 
parasite involved, intake of Spiramycin is 
stopped and other drugs are prescribed. 
However, if the PCR test result is negative, 
1 gr of Spiramycin is administered every 8 
hours to the end of pregnancy (15). 
The aim of this study evaluation of 
Toxoplasmosis in pregnancy and its 
treatment.  
Methods  
In a cross-sectional, analysis study 
conducted at the Department of Obstetrics 
and Gynecology of Qazvin University of 
Medical Sciences and Department of 
infectious diseases of Tabriz University of 
medical sciences on pregnant women 
referred to the Genecology clinics and 
Infectious Diseases clinics, the risk of 
Toxoplasma gondii and the response rate to 
the treatment were evaluated in these cases. 
As mentioned, this is a cross-sectional study 
which consisted of the pregnant women 
referred to the Tabriz health centers as the 
study population. Furthermore, in this study, 
195 pregnant women were examined during 
the period of 9 months. According to the 
investigation in terms of the Toxoplasma 
gondii antibody, 10 pregnant women(5.1%) 
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were diagnosed with the acute Toxoplasma 
infection so they were treated by 3 gr 
Spiramycin for 6 weeks. We examined our 
cases by amniocentesis in order to evaluate 
the response rate to the therapy and possible 
risk of the disease in the fetus during the 
third month of pregnancy. PCR was 
performed for the amniotic fluid samples in 
terms of the possible risk of the Toxoplasma 
infection.  
The following essential information were 
obtained and recorded from the cases 
entered and enrolled into the research. 
Demographic parameter such as age, 
Location, gravidity, parity and abortion 
history of patients was recorded.   
Now, the blood samples were obtained and 
stored in the Eppendorf tubes in order to 
examine the presence of Toxoplasma gondii 
antibody in the patients. Afterwards the 
samples were eventually preserved at - 20 ° 
C after the serum separation and finally all 
samples were tested simultaneously by using 
a commercially available ELISA kits 
(ELISA, trinity-Biotech Toxo IgG & IgM 
made by USA) according to the 
manufacturer's instructions.  The patients 
with the positive IgM and IgG results 
diagnosed with the acute Toxoplasma 
infection so they were treated by 3 gr 
Spiramycin for 6 weeks. We examined our 
cases by amniocentesis in order to evaluate 
the response rate to the treatment and the 
magnitude of fetal conflicts at the end of the 
third month of pregnancy and afterwards 
PCR was performed for the samples of 
amniotic fluid. Whereas the positive cases 
were considered as the examples with no 
prepare response to the therapy and high 
magnitude of fetal conflicts indeed so the 
abortion was definitely recommended.      
For these 10 patients, the regime of 3 gr 
Spiramycin was started daily in the third to 
the  eighth  weeks  of  pregnancy  and 
continued  to  the end of the 14th week of 
pregnancy. During weeks of 18-20 of 
pregnancy, patients went under  
amniocentesis for the diagnosis of fetal 
infection.  In the 2 cases of 10 patients, 
amniotic fluid PCR was positive. One case 
attempted to miscarriage while one decided 
to continue the pregnancy.  
Statistical Analysis  
The collected data were analyzed by SPSS-
17 statistical software. The collected data 
were expressed as percentage and mean ± 
SD. Continuous (quantitative) variables 
were compared by Independent samples and 
Paired t test. Categorical (qualitative) 
variables were compared by contingency 
tables and Chi-square test or Fisher's exact 
test. P-value 0.05 was considered 
statistically significant.  
Results and Discussion  
Mean age of studied women was 29.91 ± 
6.84 year. 115 of omen were urban and 80 
of them were rural. Demographic parameters 
of patients were shown in table I.   
In this study, 115 of the pregnant 
women had positive Anti-Toxoplasma- IgG, 
while Anti-Toxoplasma-IgM was 
negative in these patients, even as 
Toxoplasma IgG Avidity>60% was obtained 
and both Anti-Toxoplasma-IgG and IgM  
was reported negative in 70 patients. Anti-
Toxoplasma-IgG and IgM were both 
positive in 7 pregnant women with 
Toxoplasma IgG Avidity<60% which was 
considered as acute Toxoplasma infection.  
Also in 3 patients with positive Anti-
Toxoplasma-IgG and negative Anti-
Toxoplasma-IgM, Toxoplasma  IgG  
Avidity<60% was obtained which was 
indicative of acute Toxoplasma infection 
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and so these patients went under treatment. 
10 pregnant women(5.1%) were diagnosed 
with the acute Toxoplasma infection so they 
were treated by 3 gr Spiramycin for 6 
weeks.  
One of the most common parasitic infections 
in humans and warm-blooded animals is 
infection with Toxoplasma gondii, which is 
a protozoan apical complex. Infections with 
this protozoan have been reported from 
around the world. This parasite affects 
humans, a large number of mammals, and 
different bird species. It is capable of 
proliferating in a wide range of host cells. It 
is estimated that more than 500 million 
people around the globe are infected with 
this parasite (16). Congenital toxoplasmosis 
occurs during pregnancy. Therefore, if 
pregnant mothers, who are not immune to 
toxoplasmosis, develop this disease, the 
parasite will be transferred from the placenta 
to the fetus and may cause severe 
complications to the fetus. Previous studies 
in this regard indicated that the possibility of 
transfer of infection from mother to fetus is 
about 50%. Early diagnosis (in the early or 
acute phases) of infections in pregnant 
mothers is of great importance, because 
deadly infections normally outbreak as a 
result of transfer of infection from acute 
toxoplasmosis in mother (congenital 
toxoplasmosis) (16).  
The clinical pictures of congenital 
toxoplasmosis may be different depending 
on the time of infection during pregnancy, 
meanwhile death in uterus, nervous or 
ocular pathologies and an asymptomatic 
condition will be available (17). Therefore 
early detection of that at the beginning of the 
initial infection in pregnant women is 
considered very important for the protection 
of mother and the fetus (18). In study of 
Cheraghi Poor (2007), a significant 
correlation was seen between the level of 
education and Toxoplasma (19). 
In this study, all women were asymptomatic 
and acute Toxoplasma infection diagnosed 
in early pregnancy screen test. Catching an 
infection during pregnancy leaded to 
infection of embryos in 60-40% of cases 
causing serious side effects for them. 
According to CDC estimation, between 400 
and 4,000 cases of congenital toxoplasmosis 
occur in the United States annually. 
Approximately, 1-5 per 1,000 pregnant 
women experience acute toxoplasmosis 
(20). The spectrum of clinical manifestations 
of congenital toxoplasmosis is wide and in 
the first half of pregnancy, it is accompanied 
by complications such as fever, 
hydrocephaly, microcephaly, hepathospleno-
megaly, jaundice, convulsions, 
chorioretinitis (usually double-sided), brain 
calcification and mental retardation. The 
most common symptoms include 
chorioretinitis and the central nervous 
system lesions that may cause debilitating 
symptoms at birth or later in the event of 
lack of treatment (21).  
In our study, 10 wemen(5.1%) had acute 
Toxoplasma infection that underwent 
medication by 3 gr Spiramycin for 6 weeks 
and despite treatment, 2 patients(20%) was 
positive for acute Toxoplasma infection in 
the PCR of amniotic fluid.   
The sexual cycle of the parasite occurs in the 
intestine of feliformia and leads to formation 
and disposal of oocytes through their feces. 
Therefore, the parasite is indirectly 
transferred to humans and other warm-
blooded vertebrates through consumption of 
the feces (22). If a woman develops 
toxoplasmosis infection for the first time 
during her pregnancy, there will be a 
possibility for the transfer of the parasite to 
the fetus. As a result of this transmission, 
either the fetus is aborted or develops 
abnormalities (23). 
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Table.I  Demographics parameters of patients  
Location 
City Village Total P 
age 29.66 ± 6.85 30.28 ± 6.85 29.91 ± 6.84 0.539 
Parity 2.37 ± .89 2.26 ± 1.16 2.33 ± 1.01 0.449 
Abortion count .79 ± .89 .75 ± .80 .77 ± .86 0.741 
Gravidity 3.17 ± 1.33 3.01 ± 1.53 3.10 ± 1.41 0.460 
The prevalence of infection in pregnant 
women varies depending on the country. For 
instance, the prevalence varies from 9 to 
67% in European countries and varies 
between 0.8% (Korea and Vietnam) and 
55% (India, Malaysia and Nepal) in Asian 
countries. In Sudan, New Zealand and 
Brazil, anti-Toxoplasma antibodies were 
seen in 34.1%, 33% and 74.5% of pregnant 
women, respectively (24).   
A pregnant mother can transfer infections to 
the fetus during her pregnancy. However, 
with an increase in the duration of 
pregnancy, the chance of transfer increases 
and the possibility of demonstration of 
complications in the fetus decrease (15). In 
humans without signs of immuno-
suppression, acute toxoplasmosis usually 
occurs without any symptoms. That is to 
say, it is estimated that about 80 to 90% of 
infections in children and adults remain 
undiagnosed. Therefore, the asymptomatic 
nature of infection can cause many problems 
in pregnant women whose infection remain 
undiagnosed (25).  
Some of the means of diagnosing the 
mother, fetus and baby with a disease are 
serology tests, parasite detection, histology, 
and ultrasonography (26).The most common 
means of diagnosis is serology test. IgM 
antibody is normally developed in the first 
week of illness and reduces over the next 
months. However, this antibody remains in 
the body of some humans for several years 
(26).IgM antibody is developed after one or 
two weeks and is at its peak during six 
weeks. It is minimized during two years and 
then remains in the body for ever. A mother 
is diagnosed with a recent development of 
diseases when the result of her previous test 
is negative and the result of the next 
serology test is positive. Moreover, if 
serology tests are positive more than 6 
months before pregnancy, no risks are posed 
to the fetus (26).  As the same of previous 
study, we used the serologic test for 
diagnosis of Toxoplasma infection in 
pregnant women.  
Conclusion  
Infection with Toxoplasma gondii is highly 
prevalent around the globe. Consumption of 
food or water contaminated with oocytes 
disposed by cats or consumption of half-
cooked meat containing tissue cysts are two 
of the main means of transmission of 
parasite to humans.  
Mothers immunity to Toxoplasma gondii 
infection during pregnancy is of significant 
importance. Non-immune pregnant women 
may be exposed to the risk of development 
toxoplasmosis.  
In this study, 10 patients had acute 
Toxoplasma infection than underwent 
treatment and despite the treatment, 2 
patients had positive PCR for Toxoplasma 
gondii that one case attempted to 
miscarriage while one decided to continue 
the pregnancy. 
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